JP2016509842A5 - - Google Patents

Download PDF

Info

Publication number
JP2016509842A5
JP2016509842A5 JP2015560302A JP2015560302A JP2016509842A5 JP 2016509842 A5 JP2016509842 A5 JP 2016509842A5 JP 2015560302 A JP2015560302 A JP 2015560302A JP 2015560302 A JP2015560302 A JP 2015560302A JP 2016509842 A5 JP2016509842 A5 JP 2016509842A5
Authority
JP
Japan
Prior art keywords
synthase
acid
thca
cbda
cbca
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015560302A
Other languages
English (en)
Japanese (ja)
Other versions
JP6581509B2 (ja
JP2016509842A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/018944 external-priority patent/WO2014134281A1/en
Publication of JP2016509842A publication Critical patent/JP2016509842A/ja
Publication of JP2016509842A5 publication Critical patent/JP2016509842A5/ja
Application granted granted Critical
Publication of JP6581509B2 publication Critical patent/JP6581509B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015560302A 2013-02-28 2014-02-27 化合物を合成する化学工学プロセス及び装置 Expired - Fee Related JP6581509B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361770766P 2013-02-28 2013-02-28
US61/770,766 2013-02-28
PCT/US2014/018944 WO2014134281A1 (en) 2013-02-28 2014-02-27 Biosynthesis of cannabinoids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018025851A Division JP6724052B2 (ja) 2013-02-28 2018-02-16 カンナビノイドの生合成

Publications (3)

Publication Number Publication Date
JP2016509842A JP2016509842A (ja) 2016-04-04
JP2016509842A5 true JP2016509842A5 (https=) 2017-02-16
JP6581509B2 JP6581509B2 (ja) 2019-09-25

Family

ID=51428796

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015560302A Expired - Fee Related JP6581509B2 (ja) 2013-02-28 2014-02-27 化合物を合成する化学工学プロセス及び装置
JP2018025851A Expired - Fee Related JP6724052B2 (ja) 2013-02-28 2018-02-16 カンナビノイドの生合成
JP2019205366A Pending JP2020022507A (ja) 2013-02-28 2019-11-13 カンナビノイドの生合成

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2018025851A Expired - Fee Related JP6724052B2 (ja) 2013-02-28 2018-02-16 カンナビノイドの生合成
JP2019205366A Pending JP2020022507A (ja) 2013-02-28 2019-11-13 カンナビノイドの生合成

Country Status (9)

Country Link
US (8) US9359625B2 (https=)
EP (1) EP2961402B1 (https=)
JP (3) JP6581509B2 (https=)
CN (1) CN105555265A (https=)
AU (2) AU2014223458A1 (https=)
BR (1) BR112015020332A2 (https=)
CA (2) CA3012383C (https=)
IL (1) IL240830B (https=)
WO (1) WO2014134281A1 (https=)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3012383C (en) 2013-02-28 2021-03-02 Teewinot Technologies Limited Biosynthesis of cannabinoids
CA2990071C (en) 2014-07-14 2023-01-24 Librede Inc. Production of cannabigerolic acid
US11293038B2 (en) 2014-07-14 2022-04-05 Librede Inc. Production of cannabinoids in yeast
CN109593651A (zh) * 2014-08-25 2019-04-09 蒂威诺特科技有限公司 用于大麻素化合物的同时生产的设备和方法
BR122021018502B1 (pt) 2014-10-21 2022-05-03 United Cannabis Corp Formulação de canabinoide líquida
MX395015B (es) 2014-12-12 2025-03-24 Ojai Energetics Pbc Composiciones microencapsuladas de cannabinoides
US10350165B2 (en) 2014-12-12 2019-07-16 Ojai Energetics Pbc Methods and systems for forming stable droplets
WO2017175064A1 (en) * 2016-04-04 2017-10-12 Full Spectrum Laboratories Ltd Bioenzymatic synthesis of tetrahydrocannabivarin (thc-v), cannabinol (cbn), and cannabivarin (cbv) and their use as therapeutic agents
AU2017250303B2 (en) * 2016-04-15 2019-09-26 Teewinot Technologies Limited Biosynthesis of cannabinoid prodrugs
BR112018071518A2 (pt) 2016-04-22 2019-02-19 Receptor Life Sciences, Inc. compostos medicinais à base de planta de ação rápida e suplementos nutricionais
NZ749229A (en) * 2016-06-15 2026-01-30 Ojai Energetics Pbc Methods and compositions for reducing oxidative stress
WO2018091551A1 (en) * 2016-11-15 2018-05-24 Full Spectrum Laboratories Ltd Bio-stable cannabinoid compounds and methods for enhancing their physiological concentration
EA201892396A1 (ru) 2016-12-02 2019-04-30 Ресептор Лайф Сайенсиз, Инк. Быстродействующие растительные лекарственные соединения и биологически активные добавки
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
SG11201907504PA (en) 2017-02-17 2019-09-27 Hyasynth Biologicals Inc Method and cell line for production of phytocannabinoids and phytocannabinoid analogues in yeast
BR112019019966A2 (pt) 2017-03-24 2020-04-28 Trait Biosciences Inc biossíntese in vivo de alto nível e isolamento de canabinoides solúveis em água em sistemas de plantas
AU2018260710B2 (en) * 2017-04-26 2022-07-21 Teewinot Technologies Limited Apparatus, methods and composition for synthesis of cannabinoid compounds
CN110914416B (zh) 2017-04-27 2023-07-21 加州大学董事会 产生大麻素和大麻素衍生物的微生物和方法
CN111465700A (zh) * 2017-07-11 2020-07-28 特征生物科学公司 在酵母和植物细胞悬浮培养物中产生水溶性大麻素化合物和材料组合物
US11946059B2 (en) 2017-07-11 2024-04-02 Trait Biosciences, Inc. In vivo generation of water-soluble cannabinoids in plant cell suspension cultures
US11905543B2 (en) 2017-07-11 2024-02-20 Trait Biosceinces, Inc. In vivo generation of water-soluble acetylated cannabinoid glycoside compounds in plant cell suspension cultures
CN110892075A (zh) 2017-07-12 2020-03-17 生物医学股份有限公司 在酵母中生产大麻素
KR20200070237A (ko) 2017-09-05 2020-06-17 인메드 파마슈티컬스 인코포레이티드 칸나비노이드 생성물의 생합성을 위한 대장균의 대사 조작
EP3691442A4 (en) 2017-10-03 2021-07-07 The Regents of the University of Colorado PROCESS FOR DIFFERENTIATING CANNABIS PLANT CULTIVARS BASED ON CANNABINOID SYNTHASE PARALOGUES
CN114703347A (zh) 2017-10-20 2022-07-05 杰富意钢铁株式会社 高强度钢板及其制造方法
CA3089994A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
CA3098351A1 (en) 2018-04-23 2019-10-31 Renew Biopharma, Inc. Variant cannbinoid synthases and methods and uses thereof
US10801049B2 (en) 2018-06-14 2020-10-13 Syntiva Therapeutics, Inc. Genetically engineered microorganisms and processes for the production of cannabinoids from a carbon source precursor
WO2020077153A1 (en) * 2018-10-10 2020-04-16 Canopy Holdings, LLC Synthesis of cannabigerol
US11993563B2 (en) 2018-10-31 2024-05-28 Enantia S.L. Solid compositions of cocrystals of cannabinoids
EP3883595A4 (en) 2018-11-19 2022-12-14 Receptor Holdings, Inc. N-ACYLATED FATTY AMINO ACIDS TO REDUCE ABSORPTION VARIABILITY IN CANNABINOID-BASED COMPOSITIONS
CN109734591A (zh) * 2018-12-26 2019-05-10 江苏暨明医药科技有限公司 一种大麻二酚中间体及其制备方法与及应用
EP3931330A4 (en) 2019-02-25 2023-03-15 Ginkgo Bioworks, Inc. BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS
EP3934641A4 (en) 2019-03-07 2022-12-21 Ilera Therapeutics LLC FORMULATIONS FOR THE TREATMENT OF SYMPTOMS ACCOMPLISHED WITH AUTISM
WO2020210810A1 (en) 2019-04-12 2020-10-15 Renew Biopharma, Inc. Compositions and methods for using genetically modified enzymes
WO2020236789A1 (en) * 2019-05-22 2020-11-26 Demetrix, Inc. Optimized cannabinoid synthase polypeptides
EP3983367B1 (en) 2019-06-11 2025-07-30 Symrise AG Synthesis and purification of cannabigerol and its application
US10717056B1 (en) 2019-09-09 2020-07-21 Michael Cem Gokay Method and apparatus for purification of cannabinoid extracts
JP2022551476A (ja) * 2019-10-08 2022-12-09 ベッソール ファルマ、エルエルシー カンナビノイド及びカンナビノイド酸の製造プロセス
US12497636B2 (en) 2019-10-11 2025-12-16 National University Of Singapore Recombinant Saccharomyces cerevisiae cells for cannabinoid production
CN119753051A (zh) 2019-10-11 2025-04-04 新加坡国立大学 使用大麻素合成酶由大麻萜酚酸生物合成大麻素
WO2021211611A1 (en) 2020-04-14 2021-10-21 Genomatica, Inc. Cannabinoid synthase variants and methods for their use
EP4149916A4 (en) 2020-05-12 2024-06-19 Canopy Growth Corporation Methods of synthesizing cannabigergol, cannabigerolic acid, and analogs thereof
WO2021226711A1 (en) * 2020-05-12 2021-11-18 Canopy Growth Corporation Methods of synthesizing cannabigergol, cannabigerolic acid, and analogs thereof
AU2021411968A1 (en) 2020-12-31 2023-07-13 Cookies Creative Consulting & Promotions, Inc. Compositions comprising cannabis and mushroom extracts, and uses thereof
US20220298533A1 (en) * 2021-03-22 2022-09-22 Cb Therapeutics, Inc. Biosynthetic methods for the modification of cannabinoids
EP4347854A4 (en) * 2021-06-04 2025-10-01 Amyris Inc CANNABINOID PURIFICATION PROCESSES
US20250027127A1 (en) * 2021-09-15 2025-01-23 The Regents Of The University Of California Cannabinoid production in bacteria

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5086646A (en) 1989-09-12 1992-02-11 Jamison Dale E Apparatus and method for analyzing well fluid sag
US5290701A (en) * 1991-08-28 1994-03-01 Wilkins Judd R Microbial detection system and process
US5302525A (en) * 1992-11-23 1994-04-12 National Research Council Of Canada Methylobacterium extorquwns microorganism useful for the preparation of poly-β-hydroxybutyric acid polymers
US7530461B2 (en) * 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US6113940A (en) 1997-03-03 2000-09-05 Brooke; Lawrence L. Cannabinoid patch and method for cannabis transdermal delivery
JP2000078979A (ja) 1998-09-04 2000-03-21 Taisho Pharmaceut Co Ltd テトラヒドロカンナビノール酸シンターゼ遺伝子
AR022383A1 (es) * 1998-09-18 2002-09-04 Univ Kentucky Res Found Sintasas
US6403126B1 (en) 1999-05-26 2002-06-11 Websar Innovations Inc. Cannabinoid extraction method
US6949582B1 (en) 1999-05-27 2005-09-27 Wallace Walter H Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment
JP2001029082A (ja) * 1999-07-22 2001-02-06 Yukihiro Masayama カンナビジオール酸シンターゼをコードするdna
US6730330B2 (en) 2001-02-14 2004-05-04 Gw Pharma Limited Pharmaceutical formulations
US6946150B2 (en) 2002-08-14 2005-09-20 Gw Pharma Limited Pharmaceutical formulation
WO2004016254A2 (en) 2002-08-16 2004-02-26 Immugen Pharmaceuticals, Inc. Contraceptive methods and formulations
GB0222077D0 (en) 2002-09-23 2002-10-30 Gw Pharma Ltd Methods of preparing cannabinoids from plant material
DE10335130A1 (de) * 2003-07-31 2005-02-24 Blue Membranes Gmbh Immobilisierung von Katalysatoren auf porösen Körpern auf Kohlenstoffbasis
GB2418612A (en) 2004-10-01 2006-04-05 Gw Pharma Ltd Inhibition of tumour cell migration with cannabinoids
KR20070101359A (ko) * 2005-01-28 2007-10-16 더 솔크 인스티튜트 포 바이올로지칼 스터디즈 신규한 방향족 프레닐트랜스퍼라제, 이것을 코드화한 핵산및 그의 용도
EP1868698A1 (de) 2005-04-01 2007-12-26 Basf Aktiengesellschaft Verwendung von proteinen als demulgatoren
EP1885865A4 (en) * 2005-05-12 2010-12-22 Univ North Carolina ENZYMATIC SYNTHESIS OF SULFATED POLYSACCHARIDES
JP2007020466A (ja) 2005-07-15 2007-02-01 Institute Of Physical & Chemical Research 大麻CannabissativaL.の識別方法
US9265724B2 (en) 2005-11-07 2016-02-23 Ram B. Murty Oral dosage form of tetrahydrocannabinol and a method of avoiding and/or suppressing hepatic first pass metabolism via targeted chylomicron/lipoprotein delivery
US20070104741A1 (en) 2005-11-07 2007-05-10 Murty Pharmaceuticals, Inc. Delivery of tetrahydrocannabinol
GB2434312B (en) 2006-01-18 2011-06-29 Gw Pharma Ltd Cannabinoid-containing plant extracts as neuroprotective agents
GB2450493A (en) * 2007-06-25 2008-12-31 Gw Pharma Ltd Cannabigerol for use in treatment of diseases benefiting from agonism of CB1 and CB2 cannabinoid receptors
WO2009102466A1 (en) 2008-02-14 2009-08-20 The General Hospital Corporation Well-based flow system for cell culture
GB2459125B (en) 2008-04-10 2013-01-02 Gw Pharma Ltd Method if extracting cannabichromene and its acid from Cannabis sativa plant material
US9921576B2 (en) * 2008-05-05 2018-03-20 Finesse Solutions, Inc. Virtual transmitter for bioreactor automation system
SI2285387T1 (sl) * 2008-06-13 2016-02-29 N.V. Nutricia Prehrana za preprečevanje infekcij
WO2010118240A1 (en) 2009-04-08 2010-10-14 Bristol-Myers Squibb Company A genetically stable plasmid expressing pdh and fdh enzymes
DE102009019322A1 (de) * 2009-04-30 2010-11-11 The Health Concept Gmbh Verfahren zur Herstellung von Synthetischen Cannabinoiden
US20120117686A1 (en) 2009-05-04 2012-05-10 The Regentsof The University Of California Stress-tolerant plants expressing mannosylglycerate-producing enzymes
US20110003703A1 (en) * 2009-07-01 2011-01-06 Charles Ma Nucleic Acid Hybridization and Detection Using Enzymatic Reactions on a Microarray
WO2011017798A1 (en) 2009-08-12 2011-02-17 National Research Council Of Canada Aromatic prenyltransferase from cannabis
RU2711869C3 (ru) * 2009-12-01 2022-02-02 Эббви Инк. Имидазопирролопиразиновые производные, полезные для лечения заболеваний, вызванных аномальной активностью протеинкиназ Jak1, Jak3 или Syk
GB2478595B (en) 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
CA3130705A1 (en) * 2010-04-15 2011-10-20 National Research Council Of Canada Genes and proteins for aromatic polyketide synthesis
JP5751661B2 (ja) 2010-11-02 2015-07-22 国立研究開発法人農業・食品産業技術総合研究機構 デキストラングルカナーゼ
JP2012130294A (ja) 2010-12-22 2012-07-12 Tosoh Corp 抗体結合タンパク質およびその製造方法
WO2013009928A1 (en) * 2011-07-11 2013-01-17 Organic Medical Research Cannabinoid formulations
WO2013006953A1 (en) 2011-07-13 2013-01-17 National Research Council Of Canada Genes and proteins for alkanoyl-coa synthesis
US20140057251A1 (en) 2011-08-18 2014-02-27 Medicinal Genomics Corporation Cannabis Genomes and Uses Thereof
GB2494461A (en) 2011-09-12 2013-03-13 Gw Pharma Ltd Phytocannabinoids for use in the treatment of invasive cancers or metastases
GB2514054A (en) 2011-09-29 2014-11-12 Gw Pharma Ltd A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
GB2496688B (en) 2011-11-21 2016-06-29 Gw Pharma Ltd Tetrahydrocannabivarin for use in the treatment of intestinal inflammatory diseases
AU2013239962B9 (en) 2012-03-30 2017-11-16 The Scripps Research Institute Cyclic prodrugs of duocarmycin analogs
WO2013165251A1 (en) 2012-05-03 2013-11-07 Echo Pharmaceuticals B.V. Cannabis plant isolate comprising /\9-tetrahydrocannabinol and a method for preparing such an isolate
CA3012383C (en) 2013-02-28 2021-03-02 Teewinot Technologies Limited Biosynthesis of cannabinoids
WO2014145490A2 (en) 2013-03-15 2014-09-18 Biotech Institute, Llc Breeding, production, processing and use of specialty cannabis
ES2525137B1 (es) 2013-06-13 2016-01-18 Servicio Andaluz De Salud Agentes para tratar el mieloma múltiple
US10214718B2 (en) 2013-07-01 2019-02-26 University Of Massachusetts Distributed perfusion bioreactor system for continuous culture of biological cells
US9326967B2 (en) 2013-08-22 2016-05-03 Stephen C. Perry Vaporizable cannabinoid compositions
US9655910B2 (en) 2014-03-21 2017-05-23 Bodybio Inc. Compositions and methods for treating addiction
EP3171872B1 (en) * 2014-07-21 2020-11-11 Glia, LLC Method for treating radiotherapy-and-chemotherapy associated cognitive or emotional impairment with cannabinoids
CN109593651A (zh) 2014-08-25 2019-04-09 蒂威诺特科技有限公司 用于大麻素化合物的同时生产的设备和方法
AU2018260710B2 (en) * 2017-04-26 2022-07-21 Teewinot Technologies Limited Apparatus, methods and composition for synthesis of cannabinoid compounds

Similar Documents

Publication Publication Date Title
JP2016509842A5 (https=)
ECSP18010065A (es) Proceso para la producción de cannabidiol y delta-9-tetrahidrocannabinol
JP2019526717A5 (https=)
HK1252151A1 (zh) Thca合成酶表达改变的大麻植物
WO2011101260A3 (en) Sulfonamide-containing photoresist compositions and methods of use
BR112016013316A8 (pt) método para a produção de furfural e uso de ácido metanossulfônico
BR112013028764A2 (pt) suspensão do canal de fluxo frio de um turborreator por pequenas bielas e forquilhas radiais no cárter de escape
BR112018007692A2 (pt) processo de produção de 5-hidroximetilfurfural na presença de catalisadores da família de ácidos sulfônicos homogêneos na presença de pelo menos um solvente polar aprótico
BR112018000257A2 (pt) célula hospedeira, método para produzir um haa, uso de uma célula hospedeira, método para produzir uma célula hospedeira, célula, preparação de haa, método para produzir uma composição de ácido graxo e composição de ácido graxo
MX384825B (es) Metodo para separar ramnolipidos de un caldo de fermentacion.
Jaishree et al. Antioxidant and hepatoprotective effect of the ethyl acetate extract of Enicostemma axillare (Lam). Raynal against CCL4-induced liver injury in rats.
BR112019000610A2 (pt) fator vii de coagulação de longa ação e métodos de produção do mesmo
WO2019112352A3 (ko) 홍합접착단백질의 생산 방법
ES2584802T3 (es) Procedimiento de preparación de sílice precipitada que comprende una etapa de desaglomeración en caliente
JP2016525410A5 (https=)
MX372637B (es) Proceso para la preparación de diosmina
WO2012051323A3 (en) Cryptophane derivatives and methods of use thereof
MY180919A (en) Method for producing photosensitive resin element
RU2014112487A (ru) Способ получения нанокапсул резвератрола в альгинате натрия
McCormack Wilde the “Pervert”: Oscar and Transnational (Roman Catholic) Religion
WO2016110869A3 (en) Dna molecules producing custom designed replicating and non-replicating negative stranded rna viruses and uses there of
RU2015140786A (ru) Способ получения состава с гербицидной активностью
최수연 In vitro digestibility of starch and lipid in cookies as affected by the degree of esterification of pectin
JP2016513158A5 (https=)
BR112018015481A2 (pt) processo para preparar um complexo de ciclodextrina e ingrediente farmacêutico ativo